Bioxyne has announced that it has made and supplied the nation’s first pharmaceutical-grade cannabis gummies, in what it calls “a significant milestone for Australian pharmaceutical manufacturing”. The gummies (or pastilles) were made under Good Manufacturing Practice (GMP) certification from the Therapeutic Goods Administration by Bioxyne’s wholly-owned subsidiary, Breathe Life Sciences. BLS received deposits on purchase […]